Supplementary MaterialsSupplementary Data. detected by droplet digital PCR. Secondary outcomes were disease-free and overall survival. Results mutations in exoDNA, were identified in 7.4%, 66.7%, 80%, and 85% of age-matched controls, localized, locally advanced, and metastatic PDAC patients, respectively. Comparatively, mutant cfDNA was detected in 14.8%, 45.5%, 30.8%, and 57.9% of these individuals. Higher exoMAFs were… Continue reading Supplementary MaterialsSupplementary Data. detected by droplet digital PCR. Secondary outcomes were